Cardiology, Diabetes & Nephrology at the Limits 2019: Multimedia
Monday 8th - Wednesday 10th April 2019
How the gut talks to the brain and protects the heart and kidneys
Professor Carel le Roux
Director of Metabolic Medicine Group, University College Dublin, Ireland
Are pleiotropic effects of GLP-1 agonists clinically important?
Professor Lars Ryden
The Karolinska Institute, Sweden
At the limits of lipid management – statins to PCSK9 inhibitors
Dr Erin Bohula May
Brigham & Women’s Hospital, Harvard Medical School, Boston, USA
Heart failure – are there limits to anti-diabetic therapy with SGLT2 inhibitors?
Professor Milton Packer
Baylor University Medical Center, Dallas, Texas, USA
Cross talk between kidney and circulation in diabetes
Professor Katherine Tuttle
University of Washington, Washington State, USA
Cardiovascular & renal complications in pregnancy: cardiovascular
Professor Karen Sliwa
University of Cape Town, SA
Cardiovascular & renal complications in pregnancy: renal
Professor Nigel Brunskill
University of Leicester, UK
Drugs & devices: what are the limits to cardiac dysrhythmias?
Professor John Camm
St Georges Hospital, University of London, UK
Smoke & mirrors in the world of nutrition
Professor Mike Lean
University of Glasgow, UK
Thrombolysis and device therapy for acute stroke – pushing the limits!
Professor Alan Bryer
University of Cape Town, South Africa
Vitamin D - panacea or much ado about nothing?
Professor Ravi Thadhani
Cedar-Sinai, Los Angeles, USA
Ageing, cancer & CV disease – do they have a common root?
Professor Peter Libby
Brigham & Women’s Hospital, Harvard Medical School, Boston, USA